Based on the latest figures, Repligen reports a gross margin of 53.8%, an operating margin of 7.8%, an EBITDA margin of 21.9%, and a net margin of 5.3%. All measured margins increased year over year, led by operating margin with an increase of 12 percentage points.
Over the last 3 years, Repligen recorded average margins of 47.16% gross, 0.45% operating, 19.27% EBITDA, and 1.71% net. The current gross, operating, EBITDA, and net margins are all above their three-year averages.
Gross margin expanded by 9.2 percentage points, operating margin by 12 percentage points, EBITDA margin by 7.1 percentage points, and net margin by 7.4 percentage points, led by operating margin with an increase of 12 percentage points.
Across the last 3 years, Repligen recorded an average gross margin of 47.16%. Repligen's current gross margin is 53.8% and is 6.6 percentage points above its three-year average. The highest gross margin for Repligen was 53.8% in Jun 2026, while the lowest was 43.3% in Dec 2024.
Over the last 3 years, Repligen's operating margin averaged 0.45%. The current operating margin of 7.8% is 7.4 percentage points above its three-year average. During this period, operating margin reached a high of 7.8% in Jun 2026 and a low of -5% in Dec 2024.
Repligen recorded an average EBITDA margin of 19.27% across the last 3 years. Repligen currently reports an EBITDA margin of 21.9%, 2.6 percentage points above its three-year average. During this period, EBITDA margin reached a high of 24.5% in Dec 2025 and a low of 12.7% in Dec 2024.
Repligen recorded an average net margin of 1.71% across the last 3 years. Repligen currently reports a net margin of 5.3%, 3.6 percentage points above its three-year average. The net margin for Repligen moved between -4% in Dec 2024 and 6.7% in Mar 2026.
Repligen's gross margin of 53.8% is higher than the industry average but lower than the Healthcare sector and its peers average. Looking at the Healthcare sector average of 68.3%, Repligen's gross margin is 21% lower.
The current gross margin for RGEN is 53.8% as of Jun 30, 2026.
The current operating margin for RGEN is 7.8% as of Jun 30, 2026.
The current EBITDA margin for RGEN is 21.9% as of Jun 30, 2026.
The current net margin for RGEN is 5.3% as of Jun 30, 2026.
Repligen's average margins over the last 3 years were 47.2% gross, 0.5% operating, 19.3% EBITDA, and 1.7% net.
Repligen's highest recorded margins during the past 5 years were 58.9% gross in Mar 2022, 28% operating in Dec 2022, 34.6% EBITDA in Dec 2022, and 23.2% net in Dec 2022.
In the last 5 years, the lowest margins reported by RGEN were 43.3% gross in Dec 2024, -5% operating in Dec 2024, 12.7% EBITDA in Dec 2024, and -4% net in Dec 2024.